JPRN-UMIN000040838招募中未知
A seroprevalence study of COVID-19 in IBD patients - A seroprevalence study of COVID-19 in IBD patients
Hyogo College of Medicine, Center for Inflammatory Bowel Disease, Division of Internal Medicine0 个研究点目标入组 2,000 人开始时间: 2020年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 14years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with active COVID-19
研究者
相似试验
已完成
不适用
Corona Serology Studies in IBD Patients (COSS!P)IBDinflammatory bowel disease10017969NL-OMON49552OLVG2,400
尚未招募
不适用
Covid-19 in patients with inflammatory bowel diseases: rates and courses of infection, rates of vaccination, potential side effects and antibody titers - An evaluation at the outpatient clinic for IBD of the University Hospital HeidelbergCovid-19Inflammatory Bowel DiseasesDRKS00027218niversitätsklinikum Heidelberg400
尚未招募
不适用
Seroprevalence of COVID-19 antibodies among patients living with hemophilia.CTRI/2022/06/043017Maulana Azad Medical College
尚未招募
不适用
Seroprevalence of COVID-19 antibodiesCTRI/2020/11/028967Kalinga Institute of Medical Sciences KIMS Regional Medical Research Center ICMR Bhubaneswar
招募中
不适用
COVID-19 in patients with chronic inflammatory diseases: a prospective cohort studycoronavirusCOVID-191000381610047438NL-OMON54401Reade8,000